Recommended content

Lack of attention to nanoemulsion standards could hurt cannabis manufacturers

Susan Audino

(You can have cannabis science content such as this delivered directly to your inbox. Simply sign up here for our weekly MJBizScience newsletter.)

Cannabinoid nanoemulsions have gained in popularity.

But are they safe, and have they slipped through the regulatory cracks? Is this another example of a lesson (not) learned?

Nanoemulsions are delivery mechanisms for compounds such as CBD, designed to enhance their bioavailability.

Bioavailability means “the extent a substance or drug becomes completely available to its intended biological destination(s),” according to Gary Price and Deven Patel, two researchers who published a paper on drug bioavailability last fall.


Price and Patel point out that “the dose of a drug is indirectly proportional to its bioavailability” and that, “for a drug with relatively low bioavailability, a larger dose is required to reach the minimum effective concentration threshold.”

Cannabinoids such as CBD are lipophilic, which means they do not mix

Read full article on Marijuana Business Daily

Follow us on Instagram or join us on facebook page

Be first to rate

Marijuana Business Daily

More news